Study to Evaluate the Effect of Repeat-Dose Rifampin on the Pharmacokinetics (PK) of PF-06651600
Clinical trial NCT04266509 · COMPLETED
Trial details
- NCT number
- NCT04266509
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-25
- Primary completion
- 2020-09-10
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.